However, although in many studies oxytocin was shown to increase dopaminergic activity, evidence also exist identifying conditions in which oxytocin treatment has the capacity to decrease dopaminergic activity, as, for instance, in animal models of schizophrenia, where oxytocin seems to decrease dopaminergic activity in the nucleus accumbens [109]. The gene discussed is OXT; the disease is schizophrenia.